Introduction
The aim of in ovo feeding studies is the enhancement of intestinal development by enteric modulators such as β-hydroxy-β-methylbutyrate (HMB). In ovo administration of 3 mg of ascorbic acid on days 11-15 of incubation caused a reduction in the rate of embryonic death and cull chicks (1) . In a similar study the control and experimental groups were not affected differently by the same experiment (2) . Conversely, on day 18 of incubation hatchability and chick weight were substantially reduced by the administration of 0.5 g of ascorbic acid (3) .
In ovo administration of vitamin E and thiamine had a positive impact on growth in the early stages of life (4) . In addition, in ovo HMB application resulted in 45% higher villus surface area at 3 days of age and 5% higher body weight at 10 days of age (5) , and the peptide YY positively affected the feed conversion rate (FCR), live weight, and performance (6) .
In a study of in ovo feeding with egg white protein, HMB, and carbohydrate in turkey eggs, the difference in body weight of the HMB group continued up to 7 days and had a positive impact on the humoral immune response (7). Furthermore, it was reported that in ovo L-carnitine feeding increased villus length and maltose activity (8) .
In the present study, the effects of in ovo HMB injection at different concentrations on the growth performance, intestinal health, and immunity were investigated.
Materials and methods
The study was approved by the Local Ethics Committee on Animal Experiments at Ondokuz Mayıs University (2011/40, 27.06.2011).
In ovo application time and in ovo feeding
Eggs collected from a 48-week-old breeder flock (Ross 308) were incubated under optimal conditions. Eggs of average weight (58 g ± 1.3 g) and containing live embryos on day 18 of incubation were divided into three experimental and two control groups, each containing 120 eggs. In the treatment groups, HMB solution (Sigma 55453) (0.5 mL) was injected in ovo at 0.1% (Group 1), 0.2% (Group 2), or 0.3% (Group 3). Nothing was administered to the positive control group and saline solution (0.9% NaCl) was administered to the negative control group. In ovo feeding was performed with an automatic syringe (Socorex, Cat. # 187.2.0501) and a 21 G needle introduced into the amniotic sac. To reduce the effects of environmental conditions in the coop, 114 chicks of each experimental group were divided into four subgroups. Broiler feed was used in three periods (0-10 days CP: 23%, ME: 3100 kcal/ kg; 11-21 days CP: 22%, ME: 3180 kcal/kg; and 22-42 days CP: 20%, ME: 3250 kcal/kg).
Histomorphology
Seven animals from each group were sacrificed on days 4, 20, and 42 of the study. Small intestinal (mid-ileum) villi lengths and crypt depths were measured (9).
Vaccination, serological monitoring, and microbiology
Per os Newcastle HB vaccine (Hipraviar Clone) was administered on days 4, 12, and 28 of the study. Maternal antibody levels (ELISA test) were determined from blood samples (serum) on day 4 and changes in the humoral immune response (Newcastle specific antibodies) were determined serologically on days 20 and 42 according to the manufacturer's instructions (BIOCHECK Antibody Test Kit).
Total and coliform bacterial counts were performed on small intestine samples (mid-jejunum) taken on days 4, 20, and 42 of the study. The small intestines were removed from each bird and 1 g of the content was diluted 1:9 (wt/ vol) with physiological buffer solution (log 10). Samples were serially diluted from 10 -1 to 10 -8
. Using these samples, total aerobic bacteria was enumerated on tryptic soy agar plates following incubation at 37 °C for 24 h; coliform was counted on MacConkey agar plates blue agar incubated at 37 °C for 24 h (10).
Statistics analysis
One-way ANOVA was performed to compare live weight, carcass characteristics, intestinal villi, crypt measurements, total bacteria and coliform, and antibody levels of the groups at different times; Duncan's multiple range tests were used to determine the significance of the variances between the groups. Colony forming unit data transformed to log and ANOVA were used to compare the means of the groups for transformed data. The data were presented with descriptive statistics.
Results
Live weight changes are provided in Table 1 . Weekly average feed intakes, live weight gains, and feed conversion efficiencies are provided in Table 2 . Hot carcass, breast meat, gizzard, liver, and heart weights are given in Table  3 . Intestinal villi lengths are given in Table 4 and intestinal crypt depths are provided in Table 5 . Serological results are presented in Table 6 , and total intestinal bacterial and coliform counts are given in Table 7 .
Discussion
The effects of in ovo injection of different concentrations of HMB on the growth performance, intestinal health, and immunity of broilers were investigated. Firstly, no negative effects of HMB on hatching were observed (hatching 95% in all groups). Although there were no significant differences in weekly weight changes (Table 1) , weight gains, and FCR (Table 2) between the groups at the end of the fattening period, treatment Group 2 performed better. In a different study, the in ovo administration of 30 mg of threonine resulted in a better FCR until day 7 (11). In other studies using different amino acids (12) and royal jelly (13) , FCR was better in the early period of growth (0-3 weeks), but there were no differences between the groups at the end of the experimental period. In contrast, according to our results, in ovo HMB at 0.2% had a positive effect on growth performance. : means with different superscripts in the same column are significantly different.
In ovo glutamine, sucrose, and maltose had no effect on gizzard, forestomach, and liver weights (14) , but the administration of dextrin and HMB increased body weight and pectoral muscle weight (15) . In our study, carcass, breast meat, liver, and heart weight differences between the control groups and the treatment groups were not significant (Table 3) ; however, gizzard weight was higher in treatment Group 1 (P < 0.05).
Changes in villus morphology affect nutrient absorption and production. Histopathologic examination : means with different superscripts in the same column are significantly different. : means with different superscripts in the same column are significantly different. Table 6 . Antibody levels (sample to positive control ratio) (mean ± SE). : means with different superscripts in the same column are significantly different. of the samples obtained after the sacrifices on days 4, 20, and 42 of the study revealed no significant differences between the groups in terms of villi length; however, the villi of the treatment groups were longer (Table 4) . There were no differences between the groups for the depth of intestinal crypts (Table 5) . Villi length increased, but crypt depth was not affected by the in ovo administration of butyric acid (16, 17) . HMB administration had a positive effect on villus length, crypt depth, and live weight gain (5), and villi surface area and immune response increased (18) . The early differences between the treatment groups and the controls in the present study that paralleled those of other studies (16) (17) (18) disappeared by the end of the study. In ovo 10 IU vitamin E treatment increased antibody and macrophage response and increased anti-SRBC antibody titers and the amount of phagocytic macrophages (19) , while different amounts of threonine significantly increased humoral immune response (11); however, royal jelly administration had no effect on antibody response (Newcastle vaccine) (13) . In the present study, serologic examination of blood and intestinal samples (Table 6 ) and microbiological examinations (Table 7) revealed no significant differences in antibody levels between the treatment groups, but on days 4, 20, and 42 of the study the antibody level of Group 2 was higher than in all other groups ( Table 6 ). The concentrations of total aerobic bacteria and coliform in the small intestine were affected (P < 0.001) by the in ovo administration of HMB in the present study (Table 7) . During the first days after hatching, the chicks were considered to be sensitive to infectious diseases because intestinal flora bacteria had not colonized the cecum and small intestine yet. The present study showed that the chicks became more resistant to infectious diseases because bacteria settled in the intestinal flora in the first 4 days after hatching from the in ovo administration of HMB (especially treatment Group 3).
Groups
Overall, the in ovo 0.2% HMB administration positively affected the growth performance, villi length, and antibody levels of 8-week-old broilers.
